Literature DB >> 8108123

Contrasting patterns of retinoblastoma protein expression in mouse embryonic stem cells and embryonic fibroblasts.

P Savatier1, S Huang, L Szekely, K G Wiman, J Samarut.   

Abstract

The expression of the retinoblastoma susceptibility (RB-1) gene was investigated in highly proliferating mouse embryonic stem (ES) cells and in slowly proliferating mouse embryonic fibroblasts. The RB protein was expressed at the same level in these two cell types. Mainly hyperphosphorylated RB was detected in exponentially-growing ES cells. Embryonic fibroblasts and embryonic stem cells were synchronized by colcemid block followed by mitotic shake-off. In embryonic fibroblasts, DNA replication started 10-15 h after exit from mitosis and RB was transiently dephosphorylated during the G1 phase as previously described. In ES cells, DNA replication started 2 h after release from the colcemid block but virtually no hypophosphorylated RB was observed after the release. Instead, there was a dramatic decrease in the total RB protein level between exit from mitosis and entry into S phase. These observations were made by using two different monoclonal antibodies, both in immunoblotting and immunoprecipitation experiments. Absence of hypophosphorylated RB and cell cycle-dependent change in total RB protein level may be relevant to the high proliferation rate and to the tumorigenic nature of mouse embryonic stem cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8108123

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  101 in total

1.  Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions.

Authors:  J H Dannenberg; A van Rossum; L Schuijff; H te Riele
Journal:  Genes Dev       Date:  2000-12-01       Impact factor: 11.361

2.  Microfluidics-integrated time-lapse imaging for analysis of cellular dynamics.

Authors:  Dirk R Albrecht; Gregory H Underhill; Joshua Resnikoff; Avital Mendelson; Sangeeta N Bhatia; Jagesh V Shah
Journal:  Integr Biol (Camb)       Date:  2010-03-19       Impact factor: 2.192

3.  5-Aminoimidazole-4-carboxyamide ribonucleoside induces G(1)/S arrest and Nanog downregulation via p53 and enhances erythroid differentiation.

Authors:  Hee-Don Chae; Man-Ryul Lee; Hal E Broxmeyer
Journal:  Stem Cells       Date:  2012-02       Impact factor: 6.277

4.  Ets1 is required for p53 transcriptional activity in UV-induced apoptosis in embryonic stem cells.

Authors:  Dakang Xu; Trevor J Wilson; David Chan; Elisabetta De Luca; Jiong Zhou; Paul J Hertzog; Ismail Kola
Journal:  EMBO J       Date:  2002-08-01       Impact factor: 11.598

5.  Combining competition assays with genetic complementation strategies to dissect mouse embryonic stem cell self-renewal and pluripotency.

Authors:  Dung-Fang Lee; Jie Su; Ana Sevilla; Julian Gingold; Christoph Schaniel; Ihor R Lemischka
Journal:  Nat Protoc       Date:  2012-03-22       Impact factor: 13.491

6.  Induced pluripotency leapfrogs ahead.

Authors:  Michael A Gonzalez
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-03       Impact factor: 11.205

Review 7.  MicroRNAs in embryonic stem cell function and fate.

Authors:  Gustavo Tiscornia; Juan Carlos Izpisúa Belmonte
Journal:  Genes Dev       Date:  2010-12-15       Impact factor: 11.361

8.  Loss of heterozygosity induced by a chromosomal double-strand break.

Authors:  M E Moynahan; M Jasin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

9.  Erk signaling is indispensable for genomic stability and self-renewal of mouse embryonic stem cells.

Authors:  Haixia Chen; Renpeng Guo; Qian Zhang; Hongchao Guo; Meng Yang; Zhenfeng Wu; Shan Gao; Lin Liu; Lingyi Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-19       Impact factor: 11.205

10.  Regulation of ES cell differentiation by functional and conformational modulation of p53.

Authors:  K Sabapathy; M Klemm; R Jaenisch; E F Wagner
Journal:  EMBO J       Date:  1997-10-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.